middle.news
How ReNerve’s 80% Sales Surge is Transforming Nerve Repair in US Hospitals
10:52am on Friday 30th of January, 2026 AEDT
•
Healthcare
Read Story
How ReNerve’s 80% Sales Surge is Transforming Nerve Repair in US Hospitals
10:52am on Friday 30th of January, 2026 AEDT
Key Points
80% quarterly sales growth in US healthcare market
NervAlign Nerve Cuff approved for US Department of Defence and Veterans Affairs hospitals
Launch and first sales of Empliq dermal and amniotic tissue products
Progress toward NervAlign Nerve Conduit market entry in first half of 2026
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
RENERVE (ASX:RNV)
OPEN ARTICLE